Since proteolytic release of the Teneurin-2 ICD can be promoted by homophilic interactions (Bagutti et al., 2003), it should be examined if alternative ligand-dependent mechanisms operate in tumor cells, perhaps as the result of Teneurin interactions with components of the extracellular matrix (ECM). This evidence concerns the gene TENM2 and neoplasm.